메뉴 건너뛰기




Volumn 112, Issue 428, 2005, Pages 11-13

Neuropharmacological basis of combining antidepressants

Author keywords

Antidepressants; Depression; Drug combinations; Neuropharmacology; Noradrenergic; Serotonergic

Indexed keywords

AMFEBUTAMONE; ANTIDEPRESSANT AGENT; DEXAMPHETAMINE; DOPAMINE RECEPTOR STIMULATING AGENT; MAPROTILINE; MIRTAZAPINE; NEFAZODONE; NEUROLEPTIC AGENT; NORTRIPTYLINE; REBOXETINE; SEROTONIN UPTAKE INHIBITOR; TRAZODONE; VENLAFAXINE; DOPAMINE; NORADRENALIN; SEROTONIN;

EID: 29044437265     PISSN: 00651591     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper
Times cited : (17)

References (3)
  • 1
    • 0033996834 scopus 로고    scopus 로고
    • New approaches to the treatment of refractory depression
    • FAVA M. New approaches to the treatment of refractory depression. J Clin Psychiatry 2000;61(suppl. 1):26-32.
    • (2000) J Clin Psychiatry , vol.61 , Issue.SUPPL. 1 , pp. 26-32
    • Fava, M.1
  • 2
    • 0034003858 scopus 로고    scopus 로고
    • Effects of the co-administration of mirtazapine and paroxetine on serotonergic neurotransmission in the rat brain
    • BESSON A, HADDJERI N, BLIER P, DE MONTIGNY C. Effects of the co-administration of mirtazapine and paroxetine on serotonergic neurotransmission in the rat brain. Eur Neuropsychopharmacol 2000;10:177-188.
    • (2000) Eur Neuropsychopharmacol , vol.10 , pp. 177-188
    • Besson, A.1    Haddjeri, N.2    Blier, P.3    De Montigny, C.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.